Related Experiment Video
Updated: Jun 9, 2025
06:53
Cell Population Analyses During Skin Carcinogenesis
Published on: August 21, 2013
12.4K
FGFR2 in the Development and Progression of Cutaneous Squamous Cell Cancer
Ethan M Kallenberger1, Alok Khandelwal2, Priyatosh Nath2
1Department of Otolaryngology-Head and Neck Surgery, Medical University of South Carolina, Charleston, South Carolina, USA.
Molecular Carcinogenesis
|October 28, 2024
Summary
Fibroblast growth factor receptor 2 (FGFR2) drives cutaneous squamous cell carcinoma (cSCC) growth and promotes cancer progression. Targeting FGFR2 offers a promising strategy for treating this common skin cancer.
Area of Science:
- Oncology
- Dermatology
- Molecular Biology
Background:
- Cutaneous squamous cell carcinoma (cSCC) is a prevalent skin cancer, particularly in older adults.
- Fibroblast growth factor receptor 2 (FGFR2) signaling is implicated in cSCC development and progression.
- FGFR2's role in various cancers and therapy resistance is under active investigation.
Purpose of the Study:
- To review the current understanding of FGFR2's role in healthy skin versus cSCC.
- To elucidate molecular mechanisms by which FGFR2 promotes tumorigenesis and invasion.
- To evaluate FGFR2's impact on anticancer therapy and explore novel therapeutic targets.
Main Methods:
- Literature review of studies on FGFR2 in skin biology and cancer.
- Analysis of molecular pathways regulated by FGFR2 in cSCC.
- Evaluation of clinical data and preclinical research on FGFR2-targeted therapies.
Main Results:
- FGFR2 plays distinct roles in normal skin development and cSCC pathogenesis.
- FGFR2 signaling contributes to tumor growth, invasiveness, and immunosuppression.
- FGFR2 is associated with resistance to current anticancer treatments.
Conclusions:
- Targeting FGFR2 presents a potential therapeutic avenue for cSCC.
- Understanding FGFR2's mechanisms can guide the development of novel anticancer drugs.
- Further research into FGFR2-targeted therapies is crucial for managing cSCC.
Related Concept Videos
02:38Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
01:20The Retinoblastoma Gene
4.1K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K
01:30Skin Cancer
3.9K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
3.9K
02:07Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
7.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.3K
02:23Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K